CAE Inc: RBC raises to outperform from sector perform; raises target price to C$46 from C$36
CAE•Related News
Snowflake Inc. <SNOW.N>: Jefferies Raises Target Price to $385 From $310
SNOW•
Unicycive Therapeutics posts corporate presentation on kidney disease drug pipeline, led by OLC for dialysis hyperphosphatemia
UNCY•
Dianthus Therapeutics Inc <DNTH.O>: Baird assumes coverage with outperform rating; target price $132
DNTH•
Phillips 66 <PSX.N>: Jefferies raises target price to $242 from $207
PSX•
Berkshire Hathaway <BRKb.N>: TD Cowen Raises Target Price to $529 From $481
BRK.B•